Osimertinib Active Not Recruiting Phase N/A Trials for Lung Cancer Non-Small Cell Cancer (NSCLC)

IndicationsStatusPurposePhase
Active Not RecruitingNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03370770Afatinib Osimertinib Sequencing NIS
NCT03219970Efficacy and Safety of Osimertinib for HK Chinese With Metastatic T790M Mutated NSCLC-real World Setting.